.sanofi\'s Icaria combo extends progressionfree survival in MultipleMyeloma at Phase 3 httpbit.ly2Bkwy1m pharma cancer

.@sanofi's Icaria combo extends progression-free survival in #MultipleMyeloma at Phase 3 http://bit.ly/2Bkwy1m  #pharma #cancer

13:15 EST 6 Feb 2019 | Pharmafile

. @sanofi's Icaria combo extends progression-free survival in #MultipleMyeloma at Phase 3 http://bit.ly/2Bkwy1m  #pharma #cancer

More From BioPortfolio on ".@sanofi's Icaria combo extends progression-free survival in #MultipleMyeloma at Phase 3 http://bit.ly/2Bkwy1m  #pharma #cancer"